We were asked in 2005, after the national pharmaceutical strategy initiative got started, to start reporting on non-patented medicines--generics. We are wondering whether we will be given greater responsibility in that area. In terms of the patented medicines themselves, we feel we have sufficient tools to do the work.
On March 28th, 2007. See this statement in context.